A
APT Medical Inc
SSE:688617
APT Medical Inc
SSE:688617
Price:
407.6
CNY
-0.01%
Market Closed
Market Cap:
39.6B
CNY
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
49.3
Current
45.2
Median
11.6
Industry
Higher
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=49.3
Enterprise Value
/
38.6B CNY
EBITDA
784.1m CNY
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
34.6
2-Years Forward
EV/EBITDA
27
3-Years Forward
EV/EBITDA
21.6
You don't have any saved screeners yet
